Europe Latent TB Detection Market Growth and Recent Trends by 2027

Europe Latent TB Detection Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2027
  • Status : Published
  • Report Code : TIPRE00024699
  • Category : Life Sciences
  • No. of Pages : 116
  • Available Report Formats : pdf-format excel-format
  • Last update date : September 07, 2021
Europe Latent TB Detection Market Growth and Recent Trends by 2027
Report Date: September 07, 2021   |   Report Code: TIPRE00024699 Email: sales@theinsightpartners.com

2020 Market Size

US$ 304.39 Mn

Base year value

2027 Forecast

US$ 420.88 Mn

Projected by 2027

CAGR 2021-2027

4.7 %

Growth rate

Addressable Market

US$ 2,571.26 Mn

(2021-2027)

The Europe latent TB detection market is expected to grow from US$ 304.39 million in 2020 to US$ 420.88 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027.

The UK, Germany, France, Italy, and Spain are major economies in Europe. Rising government initiatives to promote tuberculosis detection is expected to surge the market growth. The disease disproportionally affects the poor, vulnerable, undernourished, and marginalized people. Evidence from various sources such as World Health Organization (WHO) and the United Nations (UN) shows that countries such as Germany and the UK are highly populated with patients suffering from TB. Thus, the government bodies in these countries are undertaking and adopting certain schemes and initiatives in containing the disease.  Furthermore, countries of the Europe region are giving significant importance in combating TB by undertaking various funding programs. The UK government is one of the largest donor of the Global Fund to fight AIDS, tuberculosis, and malaria. Thus, the financial and medical assistance from the governments for fighting the disease and promoting the diagnosis of TB is providing a lucrative scenario for the growth of the Europe market.

In case of COVID-19, Europe is highly affected specially France followed by Spain, Italy, and Germany. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is restricting the growth of the market. The COVID-19 pandemic and associated response have impacted healthcare services globally, severely disrupting care for many communicable diseases such as tuberculosis TB. Laboratory diagnostic services, considered a cornerstone of any country's capacity to manage TB, are likely to be severely impacted by the COVID-19 pandemic due to re-allocation of resources. In England, compared with 2019, TB notifications decreased by 16.5% during April and by 37.3% during May 2020; the LTBI program was paused in response to COVID-19 in March.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe latent TB detection market. The Europe latent TB detection market is expected to grow at a good CAGR during the forecast period. 
Europe latent TB detection market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Latent TB Detection Market Segmentation 

Europe Latent TB Detection Market – By Test

  • Tuberculin Skin Test (TST)
  • Interferon Gamma Released Assay (IGRA)

Europe Latent TB Detection Market – By End User

  • Hospitals
  • Diagnostic Centers
  • Laboratories
  • Others

Europe Latent TB Detection Market, by Country

  • Germany
  • UK
  • France
  • Italy  
  • Spain  
  • Rest of Europe

Europe Latent TB Detection Market -Companies Mentioned

  • Abbott
  • ARKRAY, Inc.
  • BD 
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Lionex GmbH
  • Oxford Immunotec Ltd
  • QIAGEN
  • Serum Institute of India Pvt. Ltd.

Europe Latent TB Detection Report Scope

Report Attribute Details
Market size in 2020 US$ 304.39 Million
Market Size by 2027 US$ 420.88 Million
CAGR (2020 - 2027) 4.7%
Historical Data 2018-2019
Forecast period 2021-2027
Segments Covered By Test
  • Tuberculin Skin Test
  • Interferon Gamma Released Assay
By End User
  • Hospitals
  • Diagnostic Centers
  • Laboratories
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Abbott
  • ARKRAY, Inc.
  • BD
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • Lionex GmbH
  • Oxford Immunotec Ltd
  • QIAGEN
  • Serum Institute of India Pvt. Ltd.
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA